ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

JANX Janux Therapeutics Inc

30.99
0.06 (0.19%)
Last Updated: 19:12:03
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 2.05M1.06M2.52M2.46M1.25M8.9M439k0
Operating Income -20.28M-20.75M-15.81M-16.14M-20.16M-13.82M-35.84M-29.02M
Pre Tax Income -17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M
Net Income -17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -20.28M-20.75M-15.81M-16.14M-20.16M-13.82M-35.84M-29.02M
EBITDA -19.83M-20.28M-15.31M-15.61M-19.63M-13.32M-35.33M-28.51M
Year End 31 December 2024 201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 003.64M8.61M8.08M10.59M
Operating Income -3.77M-4.84M-32.93M-67.09M-72.98M-98.85M
Pre Tax Income -4M-6.78M-32.67M-63.06M-58.29M-68.99M
Net Income -4M-6.78M-32.67M-63.06M-58.29M-68.99M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -6.629-8.304-0.792-1.515-1.263-1.315
EBIT -3.77M-6.58M-32.93M-67.09M-72.98M-98.85M
EBITDA -3.77M-4.83M-32.82M-66.25M-71.02M-96.79M